BridgeBio Pharma, Inc. (BBIO)
Market Closed
17 Jul, 20:00
$
81. 38
+1.08
+1.345%
$
16.82B Market Cap
- P/E Ratio
- Div Yield
1.44M Volume
-3.85 Eps
$ 80.3
Previous Close 
Want to track BBIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
BridgeBio Pharma, Inc. (BBIO) Statistics
Valuation metrics
Market Cap 16.82B
Enterprise value 18.44B
Trailing P/E (ttm) -21.7
Forward P/E 361.36
PEG ratio 2.38
Price/Sales (ttm) 27.48
Price/Book (mrq) -6.99
Enterprise Value/Revenue 31.8
Enterprise Value/EBITDA -30.29
Overview
Shares outstanding 194.77M
Float 160.8M
Shares short 23.37M
% Held by insiders 0.04%
% Held by institutions 1.01%
Average volume (10 days) 1.1M
Average volume (90 days) 2.9M
Price summary
52-Week low 42.09
52-Week high 93.42
Beta 1.09
50-Day moving average 71.24
200-Day moving average 72.01
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -1.25%
Operating margin -0.98%
Operational effectiveness
Return on assets -0.53%
Return on equity 0.36%
Income Statement
Revenue (ttm) 502.08M
Revenue per share (ttm) 2.98
Quarterly revenue growth (yoy) 25.21%
Gross profit (ttm) 481.11M
EBITDA -496.63M
Net income to common (ttm) -724.93M
Diluted EPS (ttm) -3.73
Quarterly earnings growth (yoy) 25.21%
Balance Sheet
Total cash (mrq) 587.48M
Total cash per share (mrq) 4.83
Total debt (mrq) 1.86B
Total Debt/Equity (mrq) -1.49
Current ratio (mrq) 1.44%
Book value per share (mrq) -11.65
Cash Flow
Cash flow statement -445.91M
Levered free cash flow (LFCF) -325.29M
